Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiofrequency 448khz in Patients Post Covid 19 With Respiratory Sequelae.

NCT07184372 is registered in ClinicalTrials.gov with Clinica Gema Leon as lead sponsor.

NCT NCT07184372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07184372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiofrequency 448khz in Patients Post Covid 19 With Respiratory Sequelae.
Lead sponsor
Clinica Gema Leon
Phase
Not applicable
Overall status
Completed
Start date
June 16, 2021
Completion date
July 20, 2022
Enrollment
96 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cough, covid-19, dyspnea, respiratory disease